A Roundup of Reader’s Comments

Keep 'em coming

Alan Richards and docross asked us to list pharmaceuticals, biologics, and devices that could genuinely be worth investing in and benefit society. Real ones, not Zum Zum products. Instead of giving a comprehensive list, here is our strategy. 

First, we look for systemic reviews that show high-quality evidence that makes a difference to patients. For exam…